Myomo (MYO) Invested Capital (2019 - 2025)

Myomo's (MYO) quarterly Invested Capital came in at $12.5 million in Q4 2025, up 1152.71% on a QoQ basis from $1.0 million in Q3 2025.

Myomo (MYO) Invested Capital (2019 - 2025) Analysis & Trends

Myomo (MYO) has 3 years of Invested Capital data on file, last reported at $12.5 million in Q4 2025.

Quarterly Invested Capital changed N/A year-over-year to $12.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $16.0 million (changed N/A YoY) and the FY2025 annual result came in at $12.5 million, changed N/A from the prior year.
Invested Capital grew to $12.5 million in Q4 2025, from $1.0 million in the prior quarter.
In the past five years, Invested Capital ranged from a high of $12.5 million in Q4 2025 to a low of $1.0 million in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Invested Cap. (Qtr)
1	Abbott Laboratories	199.46 Bn	193.86 Bn	7.27 Bn	3.01 Bn
2	Stryker	127.41 Bn	123.93 Bn	4.50 Bn	750.00 Mn
3	Medtronic	118.87 Bn	109.65 Bn	6.41 Bn	1.79 Bn
4	Boston Scientific	73.47 Bn	72.93 Bn	3.85 Bn	1.71 Bn
5	Edwards Lifesciences	51.95 Bn	47.69 Bn	1.35 Bn	-
6	Dexcom	34.30 Bn	32.35 Bn	830.00 Mn	-
7	GE HealthCare Technologies	33.76 Bn	31.65 Bn	2.18 Bn	2.00 Mn
8	Koninklijke Philips	26.35 Bn	23.02 Bn	4.55 Bn	1.34 Bn
9	Steris	23.04 Bn	22.55 Bn	684.20 Mn	243.40 Mn
10	Myomo	72.32 Mn	53.35 Mn	-	12.53 Mn

Download Data